TRVI — Trevi Therapeutics, Inc. stock price, charts and financials

QT88Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
18.75
+0.85+4.75%
OverviewShort InterestFilings
TRVIQT88Trevi Therapeutics, Inc.·NASDAQ
18.75+4.75%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20268-KCurrent report
May 07, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
Apr 21, 2026ARSAnnual report to shareholders
Apr 21, 2026DEF 14ADefinitive proxy statement
Apr 21, 2026DEFA14AAdditional proxy soliciting materials
Apr 17, 2026424B5Prospectus
Apr 17, 20268-KCurrent report
Apr 16, 2026424B5Prospectus
Apr 10, 2026PRE 14APreliminary proxy statement
Mar 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 17, 20268-KCurrent report
Mar 17, 202610-KAnnual report
Mar 09, 20268-KCurrent report
Feb 20, 20264Statement of changes in beneficial ownership
Feb 20, 20264Statement of changes in beneficial ownership
Feb 20, 20264Statement of changes in beneficial ownership
Feb 20, 20264Statement of changes in beneficial ownership
#1 / 25 of 345
Page
▼
/ 14